InsidersTradesSigma
제이피아이헬스케어 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 제이피아이헬스케어 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 제이피아이헬스케어 has published 8 insider filings. Market capitalisation: €43.2bn. The latest transaction was reported on 15 July 2026 (Purchase). Among the most active insiders: 이승혜. All data is free.
7
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,359 of 27,989 companies
69.6
score / 100
Value77
Quality63
FCF yld4.6%
Earn yld12%
EV/EBITDA7.4x
ROE9.6%
Gross mgn42%
Net mgn11%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 July 2026
Declarations8 total
Other
Other(filed)
1,558,000 sharesKRXDART:20250826000269
1,558,000 sharesShareKRXDART:20250826000265
8 of 8 declarations
About 제이피아이헬스케어
제이피아이헬스케어 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and provision of innovative health solutions.